These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24716393)

  • 1. Is priming with sex steroids useful for defining patients who will benefit from GH treatment?
    De Sanctis V; Soliman AT; Yassin M; Di Maio S
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):284-7. PubMed ID: 24716393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and management of short stature in thalassaemia major.
    Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final heights of boys with normal growth hormone responses to provocative tests following priming.
    Gonc EN; Kandemir N; Ozon A; Alikasifoglu A
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):963-71. PubMed ID: 19209618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefits of sex steroids given as a priming prior to GH provocative test or as a growth-promoting therapy in peripubertal growth delays: Results of a retrospective study among ENDO-ERN centres.
    Galazzi E; Improda N; Cerbone M; Soranna D; Moro M; Fatti LM; Zambon A; Bonomi M; Salerno M; Dattani M; Persani L
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):219-228. PubMed ID: 32969044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic short stature: management and growth hormone treatment.
    Wit JM; Reiter EO; Ross JL; Saenger PH; Savage MO; Rogol AD; Cohen P
    Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment of idiopathic short stature: clinical studies.
    Hintz RL
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S6-8. PubMed ID: 16039887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex steroid priming for growth hormone stimulation testing in children and adolescents with short stature: A systematic review.
    Duncan G; Kiff S; Mitchell RT
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):527-535. PubMed ID: 36515075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid priming in short stature children unresponsive to GH stimulation tests: Why, who, when and how.
    Partenope C; Galazzi E; Albanese A; Bellone S; Rabbone I; Persani L
    Front Endocrinol (Lausanne); 2022; 13():1072271. PubMed ID: 36523598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A boy with "transient" growth hormone deficiency in prepubertal stage despite normal growth hormone secretion in childhood and after puberty.
    Kashimada K; Onishi T; Ono M; Miyai K; Ohta M; Mizutani S
    Endocr J; 2007 Dec; 54(6):1015-9. PubMed ID: 18000342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An auxology-based growth hormone program: update on the Australian experience.
    Werther GA; Wang M; Cowell CT
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():613-8. PubMed ID: 12795362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is testosterone and estrogen priming prior to clonidine useful in the evaluation of the growth hormone status of short peripubertal children?
    Molina S; Paoli M; Camacho N; Arata-Bellabarba G; Lanes R
    J Pediatr Endocrinol Metab; 2008 Mar; 21(3):257-66. PubMed ID: 18540253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pros and cons of sex steroid priming in growth hormone stimulation testing.
    Wetterau LA
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1049-55. PubMed ID: 23329747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.